Jun 23, 2017 11:00 am UTC| Business
STAMFORD, Conn., June 23, 2017 -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively...
German Court Decision in ParkerVision v. Apple Infringement Case Awaits Validity Ruling
Jun 23, 2017 11:00 am UTC| Business
JACKSONVILLE, Fla., June 23, 2017 -- ParkerVision, Inc. (NASDAQ:PRKR), announced today that the Regional Court of Munich is holding its decision in the ParkerVision v. Apple case until after the German Federal Patent...
Jun 23, 2017 11:00 am UTC| Business
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, June 23, 2017 -- uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced...
Jun 23, 2017 11:00 am UTC| Business
CAMBRIDGE, Mass., June 23, 2017 -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a biopharmaceutical company developing small molecule therapeutics to treat diseases caused by dysfunctional protein processing such as...
Jun 23, 2017 11:00 am UTC| Business
MADRID, Spain, June 23, 2017 -- Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today announced data...
Jun 23, 2017 11:00 am UTC| Business
MADRID, Spain, June 23, 2017 -- Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, announced that results...
Alcobra Updates on its Review of Strategic Alternatives
Jun 23, 2017 11:00 am UTC| Business
TEL AVIV, Israel, June 23, 2017 -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to treat significant unmet clinical needs, today announced that its Board...